{"SPADE_UN_15639": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15639", "Peptide Name": "DAP1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "LWKRWVGVWRKWL", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (IC50=11.9 µM); NCI/ADR-RES (IC50=14.0 µM); T24 (IC50=15.3 µM); OVCAR-3 (IC50=8.6 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HUVEC:IC50=19.5 μM; NL20:IC50=19.0 μM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C92H133N25O14", "Mass": 1813.2, "PI": 12.0, "Net Charge": 4, "Hydrophobicity": -0.37, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers", "Pubmed ID": "33184577", "Reference": "Cell Mol Bioeng. 2020 Jun 24;13(5)447-461.", "Author": "Aronson MR, Dahl ES, Halle JA, Simonson AW, Gogal RA, Glick AB, Aird KM, Medina SH.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33184577"}], "Frequent Amino Acids": "WKL", "Absent Amino Acids": "ACDEFHIMNOPQSTUY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_05809", "Similarity": 1.0, "Sequence": "KKSKQLWKR"}, {"SPADE_ID": "SPADE_UN_23061", "Similarity": 1.0, "Sequence": "QLLWKKRWWR"}, {"SPADE_ID": "SPADE_N_08609", "Similarity": 1.0, "Sequence": "RKWLFW"}]}}}